Product Description: Intermediate of tranexamic Acid-13C2,15N (Aminomethylbenzoic acid-13C2,15N) is 13C and 15N labeled 4-(Aminomethyl)benzoic acid. 4-(Aminomethyl)benzoic acid is a competitive inhibitor of PepT1 and has antifibrinolytic activity[1].
Applications: Cancer-programmed cell death
Formula: C6 13C2H9 15NO2
References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216./[2]Darcel N P, et al. Activation of vagal afferents in the rat duodenum by protein digests requires PepT1[J]. The Journal of nutrition, 2005, 135(6): 1491-1495.
Molecular Weight: 154.14
Research Area: Cancer
Target: Amino Acid Derivatives;Isotope-Labeled Compounds